4-Aminopyridine (4-AP) Treatment Report
See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
patients
| 35 Patients currently take 4-Aminopyridine (4-AP) | |
| 3 Patients stopped taking 4-Aminopyridine (4-AP) | |
fellowwarrior
30 mg daily since Jul 01, 2008 | |
HAWKEYE1
37.5 mg daily since Mar 01, 2008 | |
morgan
20 mg daily since Jun 24, 2008 |
Brand Names:
Fampridine, Fampridine-SR
What is 4-Aminopyridine (4-AP)?
A drug currently in phase 2 clinical trials for MS, 4-Aminopyridine blocks potassium channels and prolongs action potentials thereby increasing transmitter release at the neuromuscular junction and elsewhere.
Read more...
What we've learned
Why Patients Take 4-Aminopyridine (4-AP)
| Other | |
|---|---|
| Fatigue | |
| Stiffness/spasticity | |
| Not indicated | |
| Brain fog | |
| I walk slower tire more easily | |
| Weakness in legs | |
| Disease-related symptoms |
Patient Dosages
| 10 mg daily | 15 mg daily | 20 mg daily | 30 mg daily | 37.5 mg daily | 40 mg daily | 50 mg daily | 60 mg daily | 40 tbs. daily | N/A | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
4
|
1
|
10
|
11
|
1
|
4
|
1
|
1
|
1
|
4
|
||
How Long Current Patients Have Been Taking 4-Aminopyridine (4-AP)
Why Patients Stopped Taking 4-Aminopyridine (4-AP) (multiple reasons could be selected)
| Other |
|---|
How Long Patients Took 4-Aminopyridine (4-AP) Before Stopping
Average:
4-Aminopyridine (4-AP) Ratings
|
|
|
|---|---|
|
|
|
|
|